Product Description
Product Name: Rucaparib Tablets
Strength: 300 mg
Form: Oral Tablet
Category: Anticancer / PARP Inhibitor
Indication: Ovarian Cancer, Prostate Cancer
Rucaparib 300 mg Tablets is a targeted oral anticancer medication used in the treatment of advanced ovarian and prostate cancers, particularly in patients with BRCA mutations or other deficiencies in DNA repair mechanisms. It belongs to the class of PARP (Poly ADP-Ribose Polymerase) inhibitors, which help block cancer cell survival by interfering with their ability to repair damaged DNA.
